Related Experiment Video
Updated: Aug 19, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
Chui Chui Ho1, Wai Yi Siu, Jeremy P H Chow
1Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong.
Abstract:
Topoisomerase II poisons like Adriamycin (ADR, doxorubicin) are clinically important chemotherapeutic agents. Adriamycin-induced DNA damage checkpoint activates ATM and ATR, which could in turn inhibit the cell cycle engine through either CHK1 or CHK2. In this study, we characterized whether CHK1 or CHK2 is required for Adriamycin-induced checkpoint. We found that both CHK1 and CHK2 were phosphorylated after Adriamycin treatment. Several lines of evidence from dominant-negative mutants, short hairpin RNA (shRNA), and knockout cells indicated that CHK1, but not CHK2, is critical for Adriamycin-induced cell cycle arrest. Disruption of CHK1 function bypassed the checkpoint, as manifested by the increase in CDC25A, activation of CDC2, increase in histone H3 phosphorylation, and reduction in cell survival after Adriamycin treatment. In contrast, CHK2 is dispensable for Adriamycin-induced responses. Finally, we found that CHK1 was upregulated in primary hepatocellular carcinoma (HCC), albeit as an inactive form. The presence of a stockpile of dormant CHK1 in cancer cells may have important implications for treatments like topoisomerase II poisons. Collectively, the available data underscore the pivotal role of CHK1 in checkpoint responses to a variety of stresses.
Insights
Adriamycin (ADR) chemotherapy relies on DNA damage checkpoints. This study reveals CHK1, not CHK2, is crucial for ADR-induced cell cycle arrest, impacting cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Therapeutics
Background:
- Topoisomerase II inhibitors like Adriamycin (ADR) are vital chemotherapeutics.
- ADR triggers DNA damage checkpoints involving ATM, ATR, CHK1, and CHK2.
- The specific roles of CHK1 and CHK2 in ADR-induced checkpoints require clarification.
Purpose of the Study:
- To determine whether CHK1 or CHK2 is essential for Adriamycin-induced cell cycle arrest.
- To investigate the functional consequences of disrupting CHK1 or CHK2 in response to ADR.
- To explore the potential implications of CHK1 expression in hepatocellular carcinoma (HCC).
Main Methods:
- Utilizing dominant-negative mutants, short hairpin RNA (shRNA), and knockout cell lines.
- Assessing phosphorylation of CHK1 and CHK2 following Adriamycin treatment.
- Analyzing cell cycle progression markers such as CDC25A and CDC2, and histone H3 phosphorylation.
Main Results:
- Both CHK1 and CHK2 were phosphorylated upon Adriamycin exposure.
- CHK1, but not CHK2, was found to be critical for Adriamycin-induced cell cycle arrest.
- Disrupting CHK1 function led to checkpoint bypass, increased CDC25A and CDC2 activity, elevated histone H3 phosphorylation, and reduced cell survival.
- CHK1 was upregulated as an inactive form in primary hepatocellular carcinoma (HCC).
Conclusions:
- CHK1 plays a pivotal role in the cell cycle checkpoint response to Adriamycin.
- CHK2 is dispensable for Adriamycin-induced cellular responses.
- The presence of inactive CHK1 in HCC suggests potential therapeutic strategies involving topoisomerase II inhibitors.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
Meiosis II
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...

